XML 49 R39.htm IDEA: XBRL DOCUMENT v3.10.0.1
Common Stock - Private Placement of Common Stock (Details)
3 Months Ended 12 Months Ended
Nov. 14, 2017
USD ($)
director
item
$ / shares
shares
Mar. 31, 2018
USD ($)
shares
Mar. 31, 2017
USD ($)
Dec. 31, 2017
USD ($)
Private Placement of Common Stock        
Gross proceeds $ 18,000,000      
Fair value of warrant liability 14,344,000 $ 16,713,000   $ 11,862,000
Net proceeds from issuance of stock in private placement $ 17,250,000      
Additional proceeds from exercise of warrants   18,000,000    
Additional shares issuable on exercise in cash of warrants   2,958,094    
Issuance costs associated with private placement   28,000 $ 2,067,000  
Issuance costs associated with common stock   $ 1,304,000    
Private placement        
Private Placement of Common Stock        
Number of warrants issued per common stock | shares 1      
Issuance costs associated with private placement $ 750,000      
Allocation of issuance cost to warrants (as a percentage) 80.00%      
Allocation of issuance cost to common stock (as a percentage) 20.00%      
Issuance costs associated with common stock $ 152,000      
Number of days for registration 30 days      
Number of days for declaration 60 days      
Number of days for review 90 days      
Number of purchasers not registered | item 2      
HCV IX and Eli Lilly | Private placement        
Private Placement of Common Stock        
Number of affiliated directors and executive officers | director 3      
Common Stock        
Private Placement of Common Stock        
Issuance of stock (in shares) | shares   2,146,667    
Remaining proceeds allocated to common stock $ 3,656,000      
Common Stock | Private placement        
Private Placement of Common Stock        
Issuance of stock (in shares) | shares 2,958,094      
Price per share (in dollars per share) | $ / shares $ 6.085      
Warrant Liability | Private placement        
Private Placement of Common Stock        
Exercise price of warrant | $ / shares $ 6.085      
Exercise expiring period 7 years      
Other expense | Private placement        
Private Placement of Common Stock        
Issuance costs associated with warrants       $ 598,000
Minimum | HCV IX and Eli Lilly | Private placement        
Private Placement of Common Stock        
Direct Holding Common Stock Percentage 5.00%